{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:24:14Z","timestamp":1792740254307,"version":"4.5.0"},"reference-count":23,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2007,9]]},"abstract":"\nObject<\/jats:title>\nBioluminescence imaging (BLI) offers a rapid and accurate means for longitudinal study of tumor cell growth and response to therapy in rodent models. Because this technology has only recently come into use in the field of small animal imaging, applications in this area have been limited. In the current study we have applied BLI to the analysis of clinically relevant issues involving use of the DNA methylating agent temozolomide (TMZ) in a mouse model.<\/jats:p><\/jats:sec>\n\nMethods<\/jats:title>\nAn invasive glioblastoma multiforme xenograft was modified for BLI via transduction with a luciferase-encoding lentivirus. Supratentorial tumors were established in athymic nude mice that were subsequently assigned randomly to control and TMZ treatment groups, and the extent of intracranial tumor was monitored using BLI.<\/jats:p><\/jats:sec>\n\nResults<\/jats:title>\n In an experiment designed to compare the extent of antitumor effect between a single high-dose TMZ treatment and a protracted low-dose TMZ regimen, BLI revealed the protracted regimen as having superior antitumor effect, and this interpretation was consistent with results from a survival comparison between the two TMZ treatment groups. In a second experiment designed to assess the utility of BLI for testing therapies against recurrent glioblastoma multiforme, mice with intracranial tumors were retreated with TMZ at a time when BLI monitoring revealed tumor regrowth following initial TMZ treatment, and retreatment was successful in providing additional survival benefit.<\/jats:p><\/jats:sec>\n\nConclusion<\/jats:title>\n The results of these experiments indicate that BLI monitoring can be used as a surrogate for predicting survival benefit from TMZ treatment, permits early determination of relative survival benefit associated with distinct TMZ therapeutic regimens, and offers a means of investigating secondary\/salvage therapy efficacy following tumor regrowth from initial therapy.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns-07\/09\/0610","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:54:10Z","timestamp":1201179250000},"page":"610-616","source":"Crossref","is-referenced-by-count":71,"title":["Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy"],"prefix":"10.3171","volume":"107","author":[{"given":"Eduard B.","family":"Dinca","sequence":"first","affiliation":[{"name":"Neuroscience Graduate Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann N.","family":"Sarkaria","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Voicu","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalin","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel S.","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"James","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-1070610","series-title":"Cancer Res","first-page":"4363","article-title":"Phase I trial of temozolomide using an extended continuous oral schedule","volume":"58","author":"Brock","year":"1998"},{"key":"b2-1070610","series-title":"Annu Rev Biomed Eng","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.bioeng.4.111901.093336","article-title":"Advances in in vivo bioluminescence imaging of gene expression","volume":"4","author":"Contag","year":"2002"},{"key":"b3-1070610","series-title":"Eur J Cancer","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0959-8049(02)00410-0","article-title":"Advancing animal models of neoplasia through in vivo bioluminescence imaging","volume":"38","author":"Edinger","year":"2002"},{"key":"b4-1070610","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/cncr.21564","article-title":"Salvage temozolomide for prior temozolomide responders","volume":"104","author":"Franceschi","year":"2005"},{"key":"b5-1070610","series-title":"Neuro-Oncol","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1215\/S1152851704000821","article-title":"Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme","volume":"7","author":"Giannini","year":"2005"},{"key":"b6-1070610","series-title":"Cancer Cell","first-page":"5","article-title":"Spying on cancer: molecular imaging in vivo with genetically encoded reporters","volume":"7","author":"Gross","year":"2005"},{"key":"b7-1070610","series-title":"Cell","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000"},{"key":"b8-1070610","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/1078-0432.CCR-05-1803","article-title":"Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter","volume":"12","author":"Hasegawa","year":"2006"},{"key":"b9-1070610","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005"},{"key":"b10-1070610","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-06-0127","article-title":"A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy","volume":"66","author":"Hunter","year":"2006"},{"key":"b11-1070610","series-title":"J Am Stat Assoc","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958"},{"key":"b12-1070610","series-title":"Neuro-Oncol","first-page":"414","article-title":"Use of an orthotopic xenograft model to evaluate the MGMT methylation status as a predictor of temozolomide response in glioblastomas","volume":"8","author":"Kitange","year":"2006"},{"key":"b13-1070610","series-title":"Cancer Treat Rev","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ctrv.2004.12.005","article-title":"Adjuvant chemotherapy in the treatment of high grade gliomas","volume":"31","author":"Lonardi","year":"2005"},{"key":"b14-1070610","series-title":"Mol Imaging","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1162\/1535350041464865","article-title":"Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden","volume":"3","author":"Paroo","year":"2004"},{"key":"b15-1070610","series-title":"J R Stat Soc Ser A Stat Soc","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptotically efficient rank invariant procedures","volume":"135","author":"Peto","year":"1972"},{"key":"b16-1070610","series-title":"Neurologist","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/01.nrl.0000186862.77459.01","article-title":"10 questions about temozolomide and the treatment of brain tumors","volume":"11","author":"Pruitt","year":"2005"},{"key":"b17-1070610","series-title":"Cancer Res","first-page":"1160","article-title":"Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice","volume":"63","author":"Ray","year":"2003"},{"key":"b18-1070610","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/sj.neo.7900121","article-title":"Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging","volume":"2","author":"Rehemtulla","year":"2000"},{"key":"b19-1070610","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1073\/pnas.2235846100","article-title":"A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors","volume":"100","author":"Rubin","year":"2003"},{"key":"b20-1070610","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1158\/1078-0432.CCR-05-2510","article-title":"Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response","volume":"12","author":"Sarkaria","year":"2006"},{"key":"b21-1070610","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ana.20306","article-title":"Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression","volume":"57","author":"Shah","year":"2005"},{"key":"b22-1070610","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.1038\/sj.onc.1206748","article-title":"Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo","volume":"22","author":"Shah","year":"2003"},{"key":"b23-1070610","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1227\/01.NEU.0000195114.24819.4F","article-title":"Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect","volume":"58","author":"Szentirmai","year":"2006"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/107\/3\/article-p610.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/107\/3\/article-p610.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/107\/3\/article-p610.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T01:29:34Z","timestamp":1681349374000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/107\/3\/article-p610.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":23,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/jns-07\/09\/0610","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}